Aurobindo Pharma to acquire Sandoz US dermatology and oral solids divisions for $1bn
Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division of the Swiss pharmaceutical giant Novartis. The ... Read More
Sandoz US to divest dermatology and oral solids businesses to Aurobindo Pharma for $1bn
In a strategic move within the pharmaceutical industry, Sandoz US, a subsidiary of the Swiss-based Novartis, has announced the sale of its dermatology and oral ... Read More